Foundations Investment Advisors, LLC Crispr Therapeutics Ag Transaction History

Foundations Investment Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 19, 2023	SELL	$43.47 - $67.77 $2,260 - $3,524	-52 Reduced 0.72%	7,131 $400,000
Q1 2023 Apr 25, 2023	SELL	$41.0 - $56.12 $246 - $336	-6 Reduced 0.08%	7,183 $324,000
Q4 2022 Jan 11, 2023	SELL	$39.19 - $65.67 $31,704 - $53,127	-809 Reduced 10.12%	7,189 $0
Q3 2022 Oct 19, 2022	SELL	$61.1 - $83.78 $45,214 - $61,997	-740 Reduced 8.47%	7,998 $523,000
Q2 2022 Jul 08, 2022	BUY	$43.23 - $73.83 $42,451 - $72,501	982 Added 12.66%	8,738 $635,000
Q1 2022 Apr 19, 2022	SELL	$53.19 - $79.24 $904 - $1,347	-17 Reduced 0.22%	7,756 $482,000
Q4 2021 Jan 21, 2022	BUY	$70.09 - $111.29 $261,575 - $415,334	3,732 Added 92.35%	7,773 $543,000
Q3 2021 Oct 13, 2021	BUY	$110.2 - $156.64 $197,037 - $280,072	1,788 Added 79.36%	4,041 $414,000
Q2 2021 Jul 14, 2021	BUY	$100.84 - $161.89 $227,192 - $364,738	2,253 New	2,253 $325,000

489

57.9M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.1B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Foundations Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Foundations Investment Advisors, LLC with notifications on news.